BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2224681)

  • 1. New drugs for hypertension: should data precede conclusions?
    Lewanczuk RZ
    CMAJ; 1990 Nov; 143(10):993-4. PubMed ID: 2224681
    [No Abstract]   [Full Text] [Related]  

  • 2. [The ALLHAT study: contributions, limitations and prospectives].
    Mancia G
    Ital Heart J Suppl; 2003 Feb; 4(2):77-84. PubMed ID: 12762256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Resp-informations].
    Bouvier-Colle MH; Cot M; Le Goaster C
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):215-24. PubMed ID: 10804430
    [No Abstract]   [Full Text] [Related]  

  • 4. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Tritace to Tri-Plen - the South African journey.
    Cardiovasc J Afr; 2009; 20(1):69-70. PubMed ID: 19287820
    [No Abstract]   [Full Text] [Related]  

  • 8. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
    Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
    Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M
    J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cardiovascular risk with RAS inhibitor/CCB combination therapy.
    Dahlöf B
    J Hum Hypertens; 2009 Feb; 23(2):77-85. PubMed ID: 18685606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium chanel blockers safe, says UMC hypertension expert.
    J Miss State Med Assoc; 1995 May; 36(5):154. PubMed ID: 7783189
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
    Román O; Cuevas G; Bunout D
    Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASCOT - more than a horse race!
    Kjeldsen SE; Narkiewicz K; Hedner T
    Blood Press; 2005; 14(5):262-3. PubMed ID: 16257870
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium channel blockers and cardiovascular complications in hypertensive diabetics.
    Hardy KJ; Flynn CA
    J Fam Pract; 1998 Jun; 46(6):454-5. PubMed ID: 9638103
    [No Abstract]   [Full Text] [Related]  

  • 18. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in an urban population--who is treated with what and how well?
    Li C; Hedblad B; Berglund G; Janzon L
    J Hum Hypertens; 2007 Apr; 21(4):323-6. PubMed ID: 17273156
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension guidelines and goals of treatment: role of calcium antagonists.
    Hansson L
    Int J Clin Pract Suppl; 2000 Nov; (114):41-4. PubMed ID: 11221294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.